Sigma Granted Patent for REDTaq™ DNA Polymerase Product Line
News Sep 16, 2005
Sigma, a division of Sigma- Aldrich Corporation has announced that the U.S. Patent and Trademark Office granted the Company U.S. Patent Number 6,942,964, entitled "Tracer Reagents that Enhance Reaction-Product Analysis," covering the array of direct-load RED enzymes already being offered in Sigma's PCR product line.
REDTaq™ products are a blend of various DNA polymerases combined with an inert red dye. The dye allows quick visual confirmation of enzyme addition and reaction homogeneity.
The sample can also be loaded directly onto an agarose gel for electrophoresis following PCR. The red dye has no effect on downstream applications.
"Our RED enzymes have been successful as an added convenience and time-saver to the research community," said Keith Jolliff, Director of Strategic Marketing in the Biotechnology Business Unit at Sigma-Aldrich.
"This patent adds to our technology portfolio and expands our leadership in life sciences and high technology."
Sigma claims that, the RED enzyme product line covers all areas of PCR including routine amplification, hot start, long and accurate, and genomic DNA amplification.
The enzymes come in both a stand-alone format as well as a ReadyMix™ formula for added convenience.
Watch: Genome Packaging Revealed in Unprecedented DetailNews
A new study has answered century-old questions about how chromosome folding occurs.READ MORE
The BuzzBuster: Could Gene Silencing Help Silence the Housefly?News
Gene silencing dsRNA technology can reduce housefly fertility, showing promise as a pest-control method.READ MORE
Researchers Zoom in on DNA Code Being Read in CellsNews
Scientists have unveiled incredible images of how the DNA code is read and interpreted – revealing new detail about one of the fundamental processes of life. The mechanism for reading DNA and decoding it to build proteins for their needs is common to all animals and plants, and is often hijacked by cancer. The discovery of exactly how the molecular mechanism works, could open up new approaches to cancer treatment.READ MORE